You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine Response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stress Response Trial (tDCS actif, tDCS Sham)

Not yet recruiting
  • Stress Response
  • tDCS actif
  • tDCS Sham
  • (no location specified)
Apr 20, 2023

Polymorphism-Genetic, Pain, Addiction Trial run by the NIAAA (Morphine, Placebo)

Completed
Has Results
  • Polymorphism-Genetic
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2021

Impulsive Behavior, Impulse Disorders, Gambling, Pathological Trial (Subthalamic Nucleaus Deep brain stimulation)

Not yet recruiting
  • Impulsive Behavior
  • +9 more
  • Subthalamic Nucleaus Deep brain stimulation
  • (no location specified)
Sep 3, 2021

Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency Trial in Nashville (procedure,

Completed
  • Autonomic Nervous System Diseases
  • +3 more
  • Standing or upright tilt
  • +12 more
  • Nashville, Tennessee
    Vanderbilt University
May 7, 2021

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (risperidone)

Unknown status
  • Schizophrenia
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Feb 6, 2020

Cognition Disorder, Attention Deficit Disorder, Traumatic Brain Injury Trial run by the (Methylphenidate)

Completed
Has Results
  • Cognition Disorder
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 13, 2019

The Chocolate Study 2.0

Completed
  • Normal Weight
  • Chocolate
  • Grand Forks, North Dakota
    USDA Grand Forks Human Nutrition Research Center
Jan 18, 2022

Vigor and the LDR in Parkinson Disease

Recruiting
  • Parkinson Disease
  • carbidopa/levodopa, as prescribed by treating physician
  • Ann Arbor, Michigan
    University of Michigan
Dec 1, 2022

Depressive Disorder, Major Trial (L-dopa/Carbidopa, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • (no location specified)
Jun 11, 2023

Obesity, Healthy Volunteers, Overweight Trial run by the NIDDK ([c11] raclopride, [18F]fallypride)

Active, not recruiting
  • Obesity
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2022

Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)

Recruiting
  • Health
  • Edmonton, Alberta, Canada
    Clinical Physiology Research Laboratory
Apr 6, 2022

Major Depression Response to Citalopram Therapy in Anorexia

Recruiting
  • Anorexia Nervosa
  • Citalopram i.v. and p.o
  • Citalopram p.o
  • Oggebbio, Italy
    Istituto Auxologico Italiano
Mar 21, 2023

Parkinson Disease Trial in Lund, Cambridge (STEM-PD)

Recruiting
  • Parkinson Disease
  • STEM-PD
  • Lund, Sweden
  • +1 more
Dec 7, 2022

Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)

Suspended
  • Disorder of Consciousness
  • Traumatic Brain Injury
  • Amantadine + L-DOPA
  • NMDA blocker
  • New York, New York
    Weill Cornell Medicine
Sep 27, 2022

Cocaine Abuse Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Brain Dopamine Reactivity, Brain

Suspended
  • Cocaine Abuse
  • Brain Dopamine Reactivity
  • Brain Dopamine Receptor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)

Recruiting
  • Parkinson Disease
  • Lille, France
    Hopital Roger Salengro, CHU Lille
Oct 11, 2022

Psychosis Trial in Albuquerque (Lumateperone, Risperidone)

Recruiting
  • Psychosis
  • Albuquerque, New Mexico
    University of New Mexico
May 25, 2023

Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)

Recruiting
  • Cocaine Use Disorder
  • Baseline [C-11]NPA PET Scan
  • +2 more
  • Pittsburgh, Pennsylvania
    University of PIttsburgh
Jun 27, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (Risperidone/Olanzapine and PET scans)

Completed
  • Schizophrenia
  • +4 more
  • Risperidone/Olanzapine and PET scans
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Jun 2, 2022

Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,

Recruiting
  • Idiopathic Parkinson's Disease
  • PD patients H&Y=1.5-2 Medications ON
  • +4 more
  • Pozzilli, Isernia, Italy
    IRCSS Neuromed Hospital
May 18, 2022

Anorexia Nervosa Trial in San Diego (amisulpride, bromocriptine)

Recruiting
  • Anorexia Nervosa
  • San Diego, California
    University of California San Diego
Sep 2, 2021

Effect of Sulpiride on Working Memory Gating and Associated BOLD Signal in the Striatum, Effect of Sulpiride on the Influence of

Completed
  • Effect of Sulpiride on Working Memory Gating and Associated BOLD Signal in the Striatum
  • +2 more
  • Sulpiride 400 MG
  • Placebo
  • Nijmegen, Gelderland, Netherlands
    Donders Centre for Cognition, Radboud University
May 22, 2023

Late-Onset Neonatal Sepsis, Extreme Prematurity, Neonatal Hypotension Trial in Canada (Dopamine, Norepinephrine)

Not yet recruiting
  • Late-Onset Neonatal Sepsis
  • +2 more
  • Calgary, Alberta, Canada
  • +14 more
Apr 20, 2022

in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

Withdrawn
  • in Vitro Fertilization
  • Poor Responder
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Apr 7, 2022

Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)

Recruiting
  • Chronic Pain
  • Rochester, New York
    University of Rochester Medical Center
Jan 9, 2023